AVITA Medical Reports Third Quarter 2021 Financial Results
May 13, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, May 13, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and...
AVITA Medical to Announce Fiscal Third Quarter 2021 Financial Results
April 29, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, April 29, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and...
New RECELL® System Data to be Presented at 43rd Annual John A. Boswick Burn & Wound Care Symposium
April 15, 2021 08:00 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia., April 15, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
15 RECELL® System Abstracts Accepted for Presentation at 53ʳᵈ Annual American Burn Association Meeting
March 30, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, March 30, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical, Inc. Names Michael Holder as Chief Financial Officer
March 22, 2021 08:00 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, March 22, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and...
Avita Medical, Inc. Announces Closing of Offering of 3,214,250 Shares of Common Stock
March 01, 2021 18:33 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, March 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and...
AVITA Medical, Inc. Announces Pricing of Its Public Offering of Common Stock
February 25, 2021 00:30 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and...
AVITA Medical, Inc. Announces Proposed Public Offering of Common Stock
February 24, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (Nasdaq: RCEL; ASX: AVH) (“AVITA Medical”), a regenerative medicine company that is developing and...
AVITA Medical to Present at Upcoming Investor Conferences
February 18, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical Reports Full Second Quarter 2021 Financial Results
February 11, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 11, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and...